Soluble CD14 levels are increased and inversely correlated with the levels of hepatitis B surface antigen in chronic hepatitis B patients

Journal of Medical Virology

Volumn 71, Issue 2, 2003, Pages 188-194

  Steyaert, Sophia ^a   Vanlandschoot, Peter ^a   Van Vlierberghe, Hans ^a   Diepolder, Helmut ^b   Leroux Roels, Geert ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

C reactive protein; Chronic hepatitis B; HBsAg; Lipopolysaccharide binding protein; SCD14

Indexed keywords

C REACTIVE PROTEIN; CD14 ANTIGEN; HEPATITIS B SURFACE ANTIGEN; LIPOPOLYSACCHARIDE BINDING PROTEIN; RECOMBINANT ANTIGEN;

ACUTE HEPATITIS; ADOLESCENT; ADULT; AGED; ANALYTIC METHOD; ANTIGEN BINDING; ANTIGEN DETECTION; ANTIGEN EXPRESSION; ARTICLE; BINDING AFFINITY; BLOOD SAMPLING; CHRONIC HEPATITIS; CONTROLLED STUDY; CORRELATION ANALYSIS; HEPATITIS B; HEPATITIS C; HUMAN; IMMUNOASSAY; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MONOCYTE; PROTEIN BLOOD LEVEL; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION;

ACUTE-PHASE PROTEINS; ADOLESCENT; ADULT; AGED; ANTIGENS, CD14; C-REACTIVE PROTEIN; CARRIER PROTEINS; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B, CHRONIC; HEPATITIS C, CHRONIC; HUMANS; LIPOPOLYSACCHARIDES; LIVER CIRRHOSIS; MEMBRANE GLYCOPROTEINS; MIDDLE AGED;

HEPATITIS C VIRUS;

EID: 0042355695     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmv.10469     Document Type: Article

References (18)

1. Antal-Szalmás P. 2000. Evaluation of CD14 in host defense. Eur J Clin Invest 30:167-179.
2. Beutler B. 2000. Tlr4: central component of the sole mammalian LPS sensor. Curr Opin Immunol 12:20-26.
3. Hyams KC. 1995. Risks of chronicity following acute hepatitis B virus infection: a review. Clin Infect Dis 20:992-1000.
4. Jirillo E, Amati L, Caradonna L, Greco B, Cozzolongo R, Cuppone R, Piazolla G, Caccavo D, Antonaci S, Manghisi OG. 1998. Soluble (s) CD14 and plasmatic lipopolysaccharides (LPS) in patients with chronic hepatitis C before and after treatment with interferon (IFN)-alpha. Immunopharmacol Immunotoxicol 20:1-14.
5. Kaser A, Ludwiczek O, Waldenberger P, Jaschke W, Vogel W, Tilg H. 2002. Endotoxin and its binding proteins in chronic liver disease: the effect of transjugular intrahepatic portosystemic shunting. Liver 22:380-387.
6. Lien E, Aukrust P, Sundan A, Mûller F, Frøland SS, Espevik T. 1998. Elevated levels of serum-soluble CD14 in human immunodeficiency virus type 1 (HIV-1) infection: correlation to disease progression and clinical events. Blood 92:2084-2092.
7. Mahoney FJ. 1999. Update on diagnosis, management, and prevention of hepatitis B virus infection. Clin Microbiol Rev 12:351-366.
8. Oesterreicher C, Pfeffel F, Petermann D, Müller C. 1995. Increased in vitro production and serum levels of the soluble lipopolysaccharide receptor sCD14 in liver disease. J Hepatol 23:396-402.
9. Roberts WL, Sedrick R, Moulton L, Spencer A, Rifai N. 2000. Evaluation of four automated high-sensitivity C-reactive protein methods: implications for clinical and epidemiological applications. Clin Chem 45:461-468.
10. Schoonjans F, Zalata A, Depuydt CE, Comhaire FH. 1995. Medcalc: a new computer program for medical statistics. Comput Methods Program Biomed 48:257-262.
11. Schumann R, Zweigner J, 1999. A novel acute-phase marker: lipopolysaccharide binding protein (LBP). Clin Chem Lab Med 37:271-274.
12. Sozinov AS. 2002. Systemic endotoxemia during chronic viral hepatitis. Bull Exp Biol Med 133:153-155.
13. Su GL. 2002. Lipopolysaccharides in liver injury: molecular mechanisms of Kupffer cell activation. Am J Physiol Gastrointest Liver Physiol 283:G256-G265.
14. Su GL, Dorko K, Strom SC, Nüssler AK, Wang SC. 1999. CD14 expression and production by human hepatocytes. J Hepatol 31: 435-442.
15. Vanlandschoot P, Van Houtte F, Roobrouck A, Farhoudi A, Leroux-Roels G. 2002a. Hepatitis B virus surface antigen suppresses the activation of monocytes through interaction with a serum protein and a monocyte-specific receptor. J Gen Virol 83:1281-1289.
16. Vanlandschoot P, Van Houtte F, Roobrouck A, Farhoudi A, Stelter F, Peterson DL, Gomez-Gutierrez J, Gavilanes F, Leroux-Roels G. 2002b. LPS-binding protein and CD14-dependent attachment of hepatitis B surface antigen to monocytes is determined by the phospholipid moiety of the particles. J Gen Virol 83:2279-2289.
17. World Health Organization. 2000. Hepatitis B. Fact sheet WHO/204, revised October.
18. Zweigner J, Gramm HJ, Singer O, Wegscheider K, Schumann R. 2001. High concentrations of lipopolysaccharide-binding protein in serum of patients with severe sepsis or septic shock inhibit the lipopolysaccharide response in human monocytes. Blood 98:3800-3808.